Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
Article in JAMA Network Open (January 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
Article in EClinicalMedicine (April 2023)
Different associations between organ-specific immune-related adverse event and survival in non-small cell lung cancer patients treated with programmed death-1 inhibitors-based combination therapy
Article in Therapeutic Advances in Medical Oncology (January 2023)